COVID-19: Bahrain approves emergency use for regn-cov2 medicine

Report says updating treatment protocol would reduce symptoms, complications

Last updated: June 16, 2021 | 22:51

Reuters

1 MIN READ

Manama city, Bahrain

Shutterstock

Also In This Package

Photos: Biden, Putin handshake kicks off Geneva summit

Troubled zoo starts 'Sponsor an Animal' to raise money

Troubled Chile zoo starts 'Sponsor an Animal' campaign to raise money

World's top billionaires who give their wealth away

The world's top givers: Bill Gates, Warren Buffet, Azim Premji, Mackenzie Scott and other billionaires who give their wealth away

Photos: 30 turtles released back into Dubai waters

Photos: World Sea-Turtle Day, 30 turtles released back into Dubai waters

Readers' photos: Deserts in the UAE

Photos: Gulf News readers share pictures of beautiful desert sand dunes, camels in Abu Dhabi, Dubai, Sharjah, Fujairah and Ras Al Khaimah

Pakistani stars get down to business

Cairo: Bahrain on Wednesday approved the emergency use for regn-cov2 medicine, Regeneron Pharmaceuticals Incs and Roche's newly authorised COVID-19 antibody combination, as part of its coronavirus treatment protocol to treat existing cases with mild and moderate symptoms, the state news agency (BNA) reported.

The report said updating the corona treatment protocol in the kingdom would reduce symptoms complications.